Upregulation of grail is associated with impaired CD4 T cell proliferation in sepsis

Journal of Immunology

Volumn 192, Issue 5, 2014, Pages 2305-2314

  Aziz, Monowar ^a,b   Yang, Weng Lang ^a,b   Matsuo, Shingo ^a,b   Sharma, Archna ^a,b   Zhou, Mian ^a,b   Wang, Ping ^a,b  

^a FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^b DONALD AND BARBARA ZUCKER SCHOOL OF MEDICINE AT HOFSTRA NORTHWELL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE RELATED TO ANERGY IN LYMPHOCYTE PROTEIN; INTERLEUKIN 12; RECOMBINANT PROTEIN; RING FINGER PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CELL ISOLATION; CONTROLLED STUDY; DOWN REGULATION; EX VIVO STUDY; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SEPSIS; SPLEEN CELL; UPREGULATION;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; IMMUNOCHEMISTRY; INTERLEUKIN-2; MALE; MICE; REAL-TIME POLYMERASE CHAIN REACTION; SEPSIS; SPLEEN; UBIQUITIN-PROTEIN LIGASES; UP-REGULATION;

EID: 84896535128     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1302160     Document Type: Article

References (50)

1. Aziz, M., A. Jacob, W. L. Yang, A. Matsuda, and P. Wang. 2013. Current trends in inflammatory and immunomodulatory mediators in sepsis. J. Leukoc. Biol. 93: 329-342.
2. Hotchkiss, R. S., G. Monneret, and D. Payen. 2013. Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach. Lancet Infect. Dis. 13: 260-268.
3. Hotchkiss, R. S., K. W. Tinsley, P. E. Swanson, R. E. Schmieg, Jr., J. J. Hui, K. C. Chang, D. F. Osborne, B. D. Freeman, J. P. Cobb, T. G. Buchman, and I. E. Karl. 2001. Sepsis-induced apoptosis causes progressive profound depletion of B and CD4+ T lymphocytes in humans. J. Immunol. 166: 6952-6963.
4. Muenzer, J. T., C. G. Davis, K. Chang, R. E. Schmidt, W. M. Dunne, C. M. Coopersmith, and R. S. Hotchkiss. 2010. Characterization and modulation of the immunosuppressive phase of sepsis. Infect. Immun. 78: 1582-1592.
5. Delano, M. J., T. Thayer, S. Gabrilovich, K. M. Kelly-Scumpia, R. D. Winfield, P. O. Scumpia, A. G. Cuenca, E. Warner, S. M. Wallet, M. A. Wallet, et al. 2011. Sepsis induces early alterations in innate immunity that impact mortality to secondary infection. J. Immunol. 186: 195-202.
6. Carson, W. F., IV, K. A. Cavassani, T. Ito, M. Schaller, M. Ishii, Y. Dou, and S. L. Kunkel. 2010. Impaired CD4+ T-cell proliferation and effector function correlates with repressive histone methylation events in a mouse model of severe sepsis. Eur. J. Immunol. 40: 998-1010.
7. Kasten, K. R., J. Tschöp, H. S. Goetzman, L. G. England, J. R. Dattilo, C. M. Cave, A. P. Seitz, D. A. Hildeman, and C. C. Caldwell. 2010. T-cell activation differentially mediates the host response to sepsis. Shock 34: 377-383.
8. Fathman, C. G., and N. B. Lineberry. 2007. Molecular mechanisms of CD4+ T-cell anergy. Nat. Rev. Immunol. 7: 599-609.
9. Mueller, D. L. 2010. Mechanisms maintaining peripheral tolerance. Nat. Immunol. 11: 21-27.
10. Macián, F., F. García-Cózar, S. H. Im, H. F. Horton, M. C. Byrne, and A. Rao. 2002. Transcriptional mechanisms underlying lymphocyte tolerance. Cell 109: 719-731.
11. Seroogy, C. M., and C. G. Fathman. 2003. T-cell anergy: from phenotype to genotype and back. Immunol. Res. 28: 255-264.
12. Mueller, D. L. 2004. E3 ubiquitin ligases as T cell anergy factors. Nat. Immunol. 5: 883-890.
13. Anandasabapathy, N., G. S. Ford, D. Bloom, C. Holness, V. Paragas, C. Seroogy, H. Skrenta, M. Hollenhorst, C. G. Fathman, and L. Soares. 2003. GRAIL: an E3 ubiquitin ligase that inhibits cytokine gene transcription is expressed in anergic CD4+ T cells. Immunity 18: 535-547.
14. Seroogy, C. M., L. Soares, E. A. Ranheim, L. Su, C. Holness, D. Bloom, and C. G. Fathman. 2004. The gene related to anergy in lymphocytes, an E3 ubiquitin ligase, is necessary for anergy induction in CD4 T cells. J. Immunol. 173: 79-85.
15. Kriegel, M. A., C. Rathinam, and R. A. Flavell. 2009. E3 ubiquitin ligase GRAIL controls primary T cell activation and oral tolerance. Proc. Natl. Acad. Sci. USA 106: 16770-16775.
16. Lin, J. T., N. B. Lineberry, M. G. Kattah, L. L. Su, P. J. Utz, C. G. Fathman, and L. Wu. 2009. Naive CD4 T cell proliferation is controlled by mammalian target of rapamycin regulation of GRAIL expression. J. Immunol. 182: 5919-5928.
17. Nurieva, R. I., S. Zheng, W. Jin, Y. Chung, Y. Zhang, G. J. Martinez, J. M. Reynolds, S. L. Wang, X. Lin, S. C. Sun, et al. 2010. The E3 ubiquitin ligase GRAIL regulates T cell tolerance and regulatory T cell function by mediating T cell receptor-CD3 degradation. Immunity 32: 670-680.
18. Whiting, C. C., L. L. Su, J. T. Lin, and C. G. Fathman. 2011. GRAIL: a unique mediator of CD4 T-lymphocyte unresponsiveness. FEBS J. 278: 47-58.
19. Su, L. L., H. Iwai, J. T. Lin, and C. G. Fathman. 2009. The transmembrane E3 ligase GRAIL ubiquitinates and degrades CD83 on CD4 T cells. J. Immunol. 183: 438-444.
20. Lineberry, N. B., L. L. Su, J. T. Lin, G. P. Coffey, C. M. Seroogy, and C. G. Fathman. 2008. Cutting edge: the transmembrane E3 ligase GRAIL ubiquitinates the costimulatory molecule CD40 ligand during the induction of T cell anergy. J. Immunol. 181: 1622-1626.
21. Ichikawa, D., M. Mizuno, T. Yamamura, and S. Miyake. 2011. GRAIL (gene related to anergy in lymphocytes) regulates cytoskeletal reorganization through ubiquitination and degradation of Arp2/3 subunit 5 and coronin 1A. J. Biol. Chem. 286: 43465-43474.
22. Schartner, J. M., W. T. Simonson, S. A. Wernimont, L. M. Nettenstrom, A. Huttenlocher, and C. M. Seroogy. 2009. Gene related to anergy in lymphocytes (GRAIL) expression in CD4+ T cells impairs actin cytoskeletal organization during T cell/antigen-presenting cell interactions. J. Biol. Chem. 284: 34674-34681.
23. Miksa, M., R. Wu, W. Dong, H. Komura, D. Amin, Y. Ji, Z. Wang, H. Wang, T. S. Ravikumar, K. J. Tracey, and P. Wang. 2009. Immature dendritic cellderived exosomes rescue septic animals via milk fat globule epidermal growth factor-factor VIII [corrected]. J. Immunol. 183: 5983-5990.
24. Yang, W.-L., W. Perillo, D. Liou, P. Marambaud, and P. Wang. 2012. AMPK inhibitor compound C suppresses cell proliferation by induction of apoptosis and autophagy in human colorectal cancer cells. J. Surg. Oncol. 106: 680-688.
25. Bachmann, M. F., and A. Oxenius. 2007. Interleukin 2: from immunostimulation to immunoregulation and back again. EMBO Rep. 8: 1142-1148.
26. Tinsley, K. W., M. H. Grayson, P. E. Swanson, A. M. Drewry, K. C. Chang, I. E. Karl, and R. S. Hotchkiss. 2003. Sepsis induces apoptosis and profound depletion of splenic interdigitating and follicular dendritic cells. J. Immunol. 171: 909-914.
27. Wisnoski, N., C. S. Chung, Y. Chen, X. Huang, and A. Ayala. 2007. The contribution of CD4+ CD25+ T-regulatory-cells to immune suppression in sepsis. Shock 27: 251-257.
28. Remick, D. G. 2007. Pathophysiology of sepsis. Am. J. Pathol. 170: 1435-1444.
29. Roger, P. M., H. Hyvernat, M. Ticchioni, G. Kumar, J. Dellamonica, and G. Bernardin. 2012. The early phase of human sepsis is characterized by a combination of apoptosis and proliferation of T cells. J. Crit. Care 27: 384-393.
30. Monneret, G. 2005. How to identify systemic sepsis-induced immunoparalysis. Adv. Sepsis 4: 42-49.
31. Wang, P., and I. H. Chaudry. 1996. Mechanism of hepatocellular dysfunction during hyperdynamic sepsis. Am. J. Physiol. 270: R927-R938.
32. Wesche, D. E., J. L. Lomas-Neira, M. Perl, C. S. Chung, and A. Ayala. 2005. Leukocyte apoptosis and its significance in sepsis and shock. J. Leukoc. Biol. 78: 325-337.
33. Muenzer, J. T., C. G. Davis, B. S. Dunne, J. Unsinger, W. M. Dunne, and R. S. Hotchkiss. 2006. Pneumonia after cecal ligation and puncture: a clinically relevant "two-hit" model of sepsis. Shock 26: 565-570.
34. Fazal, N., and W. M. Al-Ghoul. 2007. Thermal injury-plus-sepsis contributes to a substantial deletion of intestinal mesenteric lymph node CD4 T cell via apoptosis. Int. J. Biol. Sci. 3: 393-401.
35. Hotchkiss, R. S., G. Monneret, and D. Payen. 2013. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat. Rev. Immunol. 13: 862-874.
36. Vachharajani, V. T., X. Wang, C. Brown, T. Liu, N. Buechler, B. K. Yoza, and C. E. McCall. 2013. SIRT1 inhibition: a novel treatment for sepsis induced immunosuppression. In Regulators of Innate Cell Plasticity: 46th Annual Meeting of the Society for Leukocyte Biology, October 20-22, 2013. Society for Leukocyte Biology, Newport, RI, abstract 44, p. S17.
37. Venet, F., A. Pachot, A. L. Debard, J. Bohé, J. Bienvenu, A. Lepape, and G. Monneret. 2004. Increased percentage of CD4+CD25+ regulatory T cells during septic shock is due to the decrease of CD4+CD252 lymphocytes. Crit. Care Med. 32: 2329-2331.
38. Chung, C. S., Y. X. Xu, I. H. Chaudry, and A. Ayala. 1998. Sepsis induces increased apoptosis in lamina propria mononuclear cells which is associated with altered cytokine gene expression. J. Surg. Res. 77: 63-70.
39. Song, G. Y., C. S. Chung, I. H. Chaudry, and A. Ayala. 2000. Immune suppression in polymicrobial sepsis: differential regulation of Th1 and Th2 responses by p38 MAPK. J. Surg. Res. 91: 141-146.
40. Ayala, A., G. Y. Song, C. S. Chung, K. M. Redmond, and I. H. Chaudry. 2000. Immune depression in polymicrobial sepsis: the role of necrotic (injured) tissue and endotoxin. Crit. Care Med. 28: 2949-2955.
41. Nurieva, R., S. Thomas, T. Nguyen, N. Martin-Orozco, Y. Wang, M. K. Kaja, X. Z. Yu, and C. Dong. 2006. T-cell tolerance or function is determined by combinatorial costimulatory signals. EMBO J. 25: 2623-2633.
42. Egawa, S., H. Iijima, S. Shinzaki, S. Nakajima, J. Wang, J. Kondo, S. Ishii, T. Yoshio, T. Irie, T. Nishida, et al. 2008. Upregulation of GRAIL is associated with remission of ulcerative colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 295: G163-G169.
43. Heissmeyer, V., F. Macián, S. H. Im, R. Varma, S. Feske, K. Venuprasad, H. Gu, Y. C. Liu, M. L. Dustin, and A. Rao. 2004. Calcineurin imposes T cell unresponsiveness through targeted proteolysis of signaling proteins. Nat. Immunol. 5: 255-265.
44. Soto-Nieves, N., I. Puga, B. T. Abe, S. Bandyopadhyay, I. Baine, A. Rao, and F. Macian. 2009. Transcriptional complexes formed by NFAT dimers regulate the induction of T cell tolerance. J. Exp. Med. 206: 867-876.
45. Safford, M., S. Collins, M. A. Lutz, A. Allen, C. T. Huang, J. Kowalski, A. Blackford, M. R. Horton, C. Drake, R. H. Schwartz, and J. D. Powell. 2005. Egr-2 and Egr-3 are negative regulators of T cell activation. Nat. Immunol. 6: 472-480.
46. Chang, K. C., C. A. Burnham, S. M. Compton, D. P. Rasche, R. Mazuski, J. Smcdonough, J. Unsinger, A. J. Korman, J. M. Green, and R. S. Hotchkiss. 2013. Blockade ofthe negative co-stimulatory molecules PD-1 and CTLA-4 improves survival in primary and secondary fungal sepsis. Crit. Care 17: R85.
47. Unsinger, J., M. McGlynn, K. R. Kasten, A. S. Hoekzema, E. Watanabe, J. T. Muenzer, J. S. McDonough, J. Tschoep, T. A. Ferguson, J. E. McDunn, et al. 2010. IL-7 promotes T cell viability, trafficking, and functionality and improves survival in sepsis. J. Immunol. 184: 3768-3779.
48. Inoue, S., J. Unsinger, C. G. Davis, J. T. Muenzer, T. A. Ferguson, K. Chang, D. F. Osborne, A. T. Clark, C. M. Coopersmith, J. E. McDunn, and R. S. Hotchkiss. 2010. IL-15 prevents apoptosis, reverses innate and adaptive immune dysfunction, and improves survival in sepsis. J. Immunol. 184: 1401-1409.
49. MacKenzie, D. A., J. Schartner, J. Lin, A. Timmel, M. Jennens-Clough, C. G. Fathman, and C. M. Seroogy. 2007. GRAIL is up-regulated in CD4+ CD25+ T regulatory cells and is sufficient for conversion of T cells to a regulatory phenotype. J. Biol. Chem. 282: 9696-9702.
50. Ermann, J., V. Szanya, G. S. Ford, V. Paragas, C. G. Fathman, and K. Lejon. 2001. CD4+CD25+ T cells facilitate the induction of T cell anergy. J. Immunol. 167: 4271-4275.